Quantitative analysis of multiple sclerosis patients preferences for drug treatment: a best-worst scaling study

Conclusion: This study shows that preferences for drug therapy among patients with MS are different, some of which can be explained by experiences with their disease and treatment. These findings can help to inform the focus of interactions that healthcare practitioners have with patients with MS, as well as further drug development.
Source: Therapeutic Advances in Neurological Disorders - Category: Neurology Authors: Tags: Original Research Source Type: research